Cargando…

Recapitulation of premature aging with iPSCs from Hutchinson-Gilford progeria syndrome

Detalles Bibliográficos
Autores principales:	Liu, Guang-Hui, Barkho, Basam Z., Ruiz, Sergio, Diep, Dinh, Qu, Jing, Yang, Sheng-Lian, Panopoulos, Athanasia D., Suzuki, Keiichiro, Kurian, Leo, Walsh, Christopher, Thompson, James, Boue, Stephanie, Fung, Ho Lim, Sancho-Martinez, Ignacio, Zhang, Kun, Yates, John, Belmonte, Juan Carlos Izpisua
Formato:	Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088088/ https://www.ncbi.nlm.nih.gov/pubmed/21346760 http://dx.doi.org/10.1038/nature09879

Ejemplares similares

Hutchinson-Gilford progeria syndrome
por: Bhukya, Amar Singh, et al.
Publicado: (2015)

Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome
por: Wu, Zeming, et al.
Publicado: (2018)

Ocular manifestations in the Hutchinson-Gilford progeria syndrome
por: Chandravanshi, Shivcharan L, et al.
Publicado: (2011)

Hutchinson-Gilford Progeria Versus Mandibuloacral Dysplasia
por: Mehrez, Mennat Allah I, et al.
Publicado: (2014)

microRNA deregulation in Hutchinson-Gilford Progeria
por: Roll, Patrice
Publicado: (2015)

Metabolic Dysfunction in Hutchinson–Gilford Progeria Syndrome
por: Kreienkamp, Ray, et al.
Publicado: (2020)

Single-Dose CRISPR/Cas9 Therapy Extends Lifespan of Mice with Hutchinson-Gilford Progeria Syndrome
por: Beyret, Ergin, et al.
Publicado: (2019)

An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
por: Harhouri, Karim, et al.
Publicado: (2018)

Hutchinson–Gilford Progeria Syndrome: Clinical and Molecular Characterization
por: Pachajoa, Harry, et al.
Publicado: (2020)

Hutchinson-Gilford Progeria Syndrome: A Literature Review
por: Lamis, Aselah, et al.
Publicado: (2022)

Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome
por: Díez-Díez, Miriam, et al.
Publicado: (2022)

Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment
por: Columbaro, M., et al.
Publicado: (2005)

Hutchinson-Gilford Progeria Syndrome: A Rare Genetic Disorder
por: Panigrahi, Rajat G., et al.
Publicado: (2013)

Sulforaphane enhances progerin clearance in Hutchinson–Gilford progeria fibroblasts
por: Gabriel, Diana, et al.
Publicado: (2015)

Hutchinson – Gilford progeria syndrome: A rare case report
por: Kashyap, Subhash, et al.
Publicado: (2014)

Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype
por: Gabriel, Diana, et al.
Publicado: (2016)

Progress and trends in the development of therapies for Hutchinson–Gilford progeria syndrome
por: Lai, Wing‐Fu, et al.
Publicado: (2020)

Peroxisomal abnormalities and catalase deficiency in Hutchinson-Gilford Progeria Syndrome
por: Mao, Xiaojing, et al.
Publicado: (2020)

Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson–Gilford Progeria Syndrome
por: Marcos-Ramiro, Beatriz, et al.
Publicado: (2021)

Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome
por: Mao, Xiaojing, et al.
Publicado: (2022)

Hutchinson–Gilford progeria syndrome with severe calcific aortic valve stenosis
por: Hanumanthappa, Natesh B, et al.
Publicado: (2011)

Abberent expression analysis of LMNA gene in hutchinson-gilford progeria syndrome
por: Navid, Afifa, et al.
Publicado: (2012)

Hutchinson-Gilford Progeria Syndrome with G608G LMNA Mutation
por: Kim, Hui Kwon, et al.
Publicado: (2011)

Expression of the Hutchinson-Gilford Progeria Mutation Leads to Aberrant Dentin Formation
por: Choi, Hwajung, et al.
Publicado: (2018)

Are There Common Mechanisms Between the Hutchinson–Gilford Progeria Syndrome and Natural Aging?
por: Ashapkin, Vasily V., et al.
Publicado: (2019)

Epigenetic deregulation of lamina-associated domains in Hutchinson-Gilford progeria syndrome
por: Köhler, Florian, et al.
Publicado: (2020)

In Vivo Base Editing Rescues Hutchinson-Gilford Progeria Syndrome in Mice
por: Koblan, Luke W., et al.
Publicado: (2021)

DNA methylation signatures in Blood DNA of Hutchinson–Gilford Progeria syndrome
por: Bejaoui, Yosra, et al.
Publicado: (2022)

Carotid artery dissection in Hutchinson-Gilford Progeria: a case report
por: González-Maestro, Víctor, et al.
Publicado: (2022)

Impact of MnTBAP and Baricitinib Treatment on Hutchinson–Gilford Progeria Fibroblasts
por: Vehns, Elena, et al.
Publicado: (2022)

The Molecular and Cellular Basis of Hutchinson–Gilford Progeria Syndrome and Potential Treatments
por: Batista, Noelle J., et al.
Publicado: (2023)

Model of human aging: Recent findings on Werner’s and Hutchinson-Gilford progeria syndromes
por: Ding, Shian-ling, et al.
Publicado: (2008)

Molecular ageing in progeroid syndromes: Hutchinson-Gilford progeria syndrome as a model
por: Coutinho, Henrique Douglas M, et al.
Publicado: (2009)

Hypoparathyroidism in an Egyptian child with Hutchinson-Gilford progeria syndrome: a case report
por: Kalil, Kotb Abbass Metwalley, et al.
Publicado: (2012)

Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria
por: Chojnowski, Alexandre, et al.
Publicado: (2015)

Erythrocyte Senescence in a Model of Rat Displaying Hutchinson-Gilford Progeria Syndrome
por: Chaudhary, Manoj Kumar, et al.
Publicado: (2018)

Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment
por: Piekarowicz, Katarzyna, et al.
Publicado: (2019)

Generation of a Hutchinson–Gilford progeria syndrome monkey model by base editing
por: Wang, Fang, et al.
Publicado: (2020)

Mechanisms of angiogenic incompetence in Hutchinson–Gilford progeria via downregulation of endothelial NOS
por: Gete, Yantenew G., et al.
Publicado: (2021)

Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry
por: Camafeita, Emilio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7vn5p9uqs7nghkjjd0nia7ld19